ANTIBIOTICE IASI
78 articole · RSS
Antibiotice Iasi Ends 9M 2023 with RON463.4M Turnover, Up 28%, RON76M Net Profit, More than Double the 9M 2022 Level
Romanian state-owned pharma producer Antibiotice Iasi for the first nine months of 2023 reported RON463.4 million turnover, up 28%, and RON76 million net profit, more than doubled the RON30...
Antibiotice Iasi Shareholders OK EUR25M Funding from EIB
The extraordinary general meeting of shareholders convened by drug maker Antibiotice Iasi on October 30 approved the signing of a financing contract worth EUR25 million euro, i.e. RON23 mill...
Antibiotice Iasi Looks at New Export Markets
Antibiotic Iasi, the biggest Romanian-held drug producer, is mulling new export markets, including Nordic ones, where it is trying to already develop its first local partnerships.
Antibiotice Iasi Calls Shareholders To Approve EUR25M Financing Contract With The Romanian State
Romanian state-owned pharmaceutical manufacturer Antibiotice (ATB.RO) has called shareholders for a general meeting on October 30, 2023 to secure approval for the conclusion of a financing c...
SIF Oltenia Buys 2.4% Of Antibiotice Iasi Shares In RON9.3M Deal
Antibiotice Iasi (ATB.RO), Romania’s most important generic drug manufacturer, on Thursday (May 18) informed the Bucharest Stock Exchange (BVB) that SIF Oltenia (SIF5.RO), its second largest...
Antibiotice Iasi Posts RON178M Sales in 1Q/2023, Up around 40%, Sees Net Profit Almost Triple To RON22M
Romanian pharma producer Antibiotice Iasi ended the first quarter of 203 with RON178 million sales, up around 40%, and RON22 million net profit, almost triple the level of the year-earlier p...
Antibiotice Iasi Ends 2022 With RON38.5M Net Profit, Up 29% YoY
Romanian pharmaceutical manufacturer Antibiotice Iasi (ATB.RO) said in a stock market report on Monday (Feb 27) that it ended 2022 with a net profit of RON38.5 million in 2022. up 28.6% vers...
Antibiotice Iasi Aims for RON580M Turnover and RON42M Profit in 2023
Romanian pharmaceutical producer Antibiotice Iasi has budgeted RON580 million revenues for 2023, up 11% year-on-year and RON42 million net profit, 10% higher than in 2022.
Enel X Romania To Build Solar Park For Antibiotice Iasi
Enel X Romania, part of Enel X Global Retail, the advanced energy services division of Italy’s Enel Group, will build a photovoltaic (PV) park with a total installed capacity of 2.5 MW for R...